UCB

www.ucb.com

Allee de la Recherche 60
Brussels
1070
Belgium

+32 2 559 99 99

Activities

Manufacturing | Research & Development

Related Companies

Related Content

Therapeutic: rozanolixizumab for generalised myasthenia gravis
Therapeutic: rozanolixizumab for generalised myasthenia gravis
Therapeutic: zilucoplan for myasthenia gravis
Therapeutic: zilucoplan for myasthenia gravis
Therapeutics: rozanolixizumab for primary immune thrombocytopenia
Therapeutics: rozanolixizumab for primary immune thrombocytopenia
Therapeutics: dapirolizumab for systemic lupus erythematosus
Therapeutics: dapirolizumab for systemic lupus erythematosus
UCB Pharma chooses South Korean CDMO for the third time
UCB Pharma chooses South Korean CDMO for the third time
Continuous manufacturing: making it real
Continuous manufacturing: making it real
Pharmapack Europe 2019 reveals winners
Pharmapack Europe 2019 reveals winners
Increasing competition in the psoriasis market
Increasing competition in the psoriasis market
MRC forges two new deals with industry to speed drug discovery
MRC forges two new deals with industry to speed drug discovery
UCB receives EMA approval for pre-filled pen using Bespak Technology
UCB receives EMA approval for pre-filled pen using Bespak Technology
Heptares joins consortium applying cryo-electron microscopy to structure-based drug discovery
Heptares joins consortium applying cryo-electron microscopy to structure-based drug discovery
Latest EU drug approvals span range of health issues
Latest EU drug approvals span range of health issues
UCB and Baylor College of Medicine enter neurodegeneration alliance
UCB and Baylor College of Medicine enter neurodegeneration alliance
Steve Turley joins UCB as Managing Director for UK and Ireland
Steve Turley joins UCB as Managing Director for UK and Ireland
Leukaemia – inotuzumab ozogamicin
Leukaemia – inotuzumab ozogamicin